Phase II Cancer Trials: Out of Control?

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-0163
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Phase II Cancer Clinical Trials for Biomarker-Guided Treatments

Journal of Biopharmaceutical Statistics
StatisticsProbabilityPharmacology
2017English

Phase I Cancer Clinical Trials

British Journal of Cancer
Cancer ResearchOncology
2007English

Comparison of Error Rates in Single-Arm Versus Randomized Phase II Cancer Clinical Trials

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Phase II Trials Powered to Detect Tumor Subtypes

Clinical Cancer Research
Cancer ResearchOncology
2011English

Between-Arm Comparisons in Randomized Phase II Trials

Journal of Biopharmaceutical Statistics
StatisticsProbabilityPharmacology
2009English

Predictors of Success of Phase II Pediatric Oncology Clinical Trials

Oncologist
Cancer ResearchMedicineOncology
2019English

Escalation With Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials

PLoS ONE
Multidisciplinary
2014English

Early Phase Pediatric Cancer Trials: Progress Highlights Challenges

Oncologist
Cancer ResearchMedicineOncology
2020English

Ozone-Depleting-Substance Control and Phase-Out Plan

1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy